Atria Ventures
Overview
Atria Ventures is a venture capital firm investing in biotech and healthcare, with a focus on the intersection of biotechnology and artificial intelligence. The firm seeks to invest in pre-seed and seed companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MoonPay | Nov 2021 | Series A | - |
| TRM Labs | Jun 2021 | Series A | - |
| Bio Protocol | Sep 2025 | Seed | Co-investor |
| ArcPrime | Oct 2025 | Seed | Co-investor |
| Evolv | Jan 2024 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Atria Ventures based?
Atria Ventures is headquartered in San Francisco, California, United States.
When was Atria Ventures founded?
Atria Ventures was founded in 2023.
How many portfolio companies does Atria Ventures have?
Atria Ventures has 13 portfolio companies in Caplight's dataset.
What are some companies in Atria Ventures's portfolio?
Portfolio companies visible on Caplight include MoonPay, TRM Labs, Bio Protocol, ArcPrime, Evolv.
What was Atria Ventures's most recent investment shown here?
Atria Ventures's most recent investment in this portfolio sample was in ArcPrime in 2025.
What sectors does Atria Ventures focus on?
Atria Ventures focuses on Crypto & Web3, Healthcare & Life Sciences, Healthcare & Life Sciences, Crypto & Web3, Healthcare & Life Sciences, Crypto & Web3, Crypto & Web3, Crypto & Web3, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Crypto & Web3, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Media, Entertainment & Gaming, Cybersecurity, AI, Data & Cloud Infrastructure, Enterprise Software, FinTech, Consumer & Commerce, Enterprise Software, Crypto & Web3.
What company stages does Atria Ventures focus on?
Atria Ventures typically invests at the Early stage.
What is Atria Ventures's AUM?
Atria Ventures's assets under management are estimated between $0.0 and $50.0M.